Filter
546
Text search:
drugs
and
related
substances
act
Featured
Recommendations
58
New Publications
138
Language
Document type
No document type
339
Guidelines
78
Studies & Reports
51
Manuals
34
Strategic & Response Plan
18
Training Material
14
Situation Updates
4
Fact sheets
3
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
37
South Africa
36
Kenya
31
Nigeria
17
Western and Central Europe
17
Ethiopia
15
Ghana
15
Zambia
14
Tanzania
12
Sierra Leone
10
Global
10
Uganda
9
Nepal
9
Zimbabwe
7
Namibia
7
Liberia
6
Philippines
6
Botswana
6
Malawi
5
Rwanda
4
Bangladesh
4
Eswatini/ Swaziland
4
Myanmar / Burma
4
South–East Asia Region
4
Pakistan
3
Afghanistan
3
Germany
3
Syria
3
Indonesia
3
Ukraine
3
Eastern Europe and Central Asia
3
Eastern Europe
3
USA
2
North Macedonia
2
Lesotho
2
Sri Lanka
2
Latin America and the Carribbean
2
Asia
2
Africa
2
Southern Africa
2
Guinea
1
Burkina Faso
1
Iraq
1
Cambodia
1
Thailand
1
Papua New Guinea
1
Switzerland
1
Libya
1
Yemen
1
Bhutan
1
Poland
1
Albania
1
Russia
1
Estonia
1
Moldova
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
30
Women & Child Health
24
Public Health
21
Capacity Building
12
Key Resources
8
Pharmacy & Technologies
7
Toolboxes
Mental Health
77
HIV
49
Pharmacy
48
AMR
35
TB
18
Caregiver
17
NCDs
11
COVID-19
10
Planetary Health
9
Rapid Response
8
Specific Hazards
7
Ebola
6
Global Health Education
6
Refugee
5
Conflict
3
Natural Hazards
2
Disability
1
Cholera
1
Zika
1
Health Financing Toolbox
1
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers
...
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004
Prepared by NGOs: “Legalife-Ukraine”, “Insight”, “Positive Women”, and “Svitanok”
For the submission to the 66th CEDAW Session Geneva, Switzerland
13 February 2017 - 03 March 2017
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization servi
...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchia
...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
The guidelines begin with an overview of the determinants of mental health among children and adolescents before reviewing related South African policies
...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available
...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical
...
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous
...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses
...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa
...
A summary of the national drug situation
Accessed: 22.03.2019
A summary of the national drug situation
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased mor
...